Page last updated: 2024-08-21

malondialdehyde and ro13-9904

malondialdehyde has been researched along with ro13-9904 in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's5 (71.43)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Chaudhary, M; Dwivedi, VK; Soni, A1
Chaudhary, M; Dwivedi, VK; Kumar, S; Shrivastava, SM; Soni, A1
Abnous, K; Amin, B; Hajhashemi, V; Hosseinzadeh, H1
Çavuşoğlu, T; Erbas, O; Özkeşkek, K; Solmaz, V; Tümer, MK; Uyanikgil, Y1
Andrisic, L; Jarocka-Karpowicz, I; Moniuszko-Malinowska, A; Pancewicz, S; Skrzydlewska, E; Zajkowska, J; Zarkovic, N; Łuczaj, W1
Abdel-Daim, MM; Abushouk, AI; Al-Sultan, NK; Alahmari, A; Alarifi, S; AlBasher, G; Aleya, L; Alghamdi, J; Ali, D; Alkahtane, AA; Alkahtani, S; Almeer, RS; Bungau, SG; El-Bialy, BE1
Alver, A; Arslan, E; Biyik, MO; Bodur, A; Guvercin, AR; Kosucu, M1

Other Studies

7 other study(ies) available for malondialdehyde and ro13-9904

ArticleYear
Ceftriaxone-vancomycin drug toxicity reduction by VRP 1020 in Mus musculus mice.
    Current clinical pharmacology, 2009, Volume: 4, Issue:2

    Topics: Amino Acids; Animals; Anti-Bacterial Agents; Catalase; Ceftriaxone; Drug Combinations; Kidney; Liver; Male; Malondialdehyde; Mice; Oxidative Stress; Superoxide Dismutase; Vancomycin

2009
Evaluation of Vancoplus versus ceftriaxone against cephalosporin resistance MRSA strain in experimental meningitis model.
    Cardiovascular & hematological disorders drug targets, 2010, Volume: 10, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Cephalosporin Resistance; Malondialdehyde; Meningitis, Bacterial; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Models, Animal; Rats; Staphylococcal Infections; Vancomycin

2010
Ceftriaxone, a beta-lactam antibiotic, modulates apoptosis pathways and oxidative stress in a rat model of neuropathic pain.
    BioMed research international, 2014, Volume: 2014

    Topics: Animals; Anti-Bacterial Agents; Apoptosis; Apoptosis Regulatory Proteins; Ceftriaxone; Disease Models, Animal; Glutathione; Male; Malondialdehyde; Neuralgia; Oxidative Stress; Rats; Rats, Wistar; Time Factors

2014
Positive effects of ceftriaxone on pentylenetetrazol-induced convulsion model in rats.
    The International journal of neuroscience, 2016, Volume: 126, Issue:1

    Topics: Animals; Anticonvulsants; Brain; Ceftriaxone; Convulsants; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electrodes, Implanted; Electroencephalography; GABA Antagonists; Lipid Peroxidation; Male; Malondialdehyde; Myoclonus; Pentylenetetrazole; Random Allocation; Rats; Rats, Sprague-Dawley; Seizures; Superoxide Dismutase

2016
Lipid peroxidation in the pathogenesis of neuroborreliosis.
    Free radical biology & medicine, 2016, Volume: 96

    Topics: Adult; Aged; Aged, 80 and over; Aldehydes; Borrelia burgdorferi; Ceftriaxone; Docosahexaenoic Acids; F2-Isoprostanes; Female; Glutathione Peroxidase; Humans; Lipid Peroxidation; Lyme Neuroborreliosis; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Phospholipases A2

2016
The ameliorative effects of ceftriaxone and vitamin E against cisplatin-induced nephrotoxicity.
    Environmental science and pollution research international, 2019, Volume: 26, Issue:15

    Topics: Animals; Antioxidants; Catalase; Ceftriaxone; Cisplatin; Creatinine; Glutathione; Glutathione Peroxidase; Injections, Intraperitoneal; Kidney; Male; Malondialdehyde; Nitric Oxide; Rats; Superoxide Dismutase; Urea; Vitamin E

2019
Is ceftriaxone effective in experimental brain ischemia/reperfusion injury?
    Bratislavske lekarske listy, 2020, Volume: 121, Issue:12

    Topics: Animals; Brain; Brain Ischemia; Ceftriaxone; Malondialdehyde; Neuroprotective Agents; Oxidative Stress; Rats; Reperfusion Injury

2020